FDA puts Bellicum’s cancer cell therapy trial on holdThe FDA has placed a clinical hold on a phase 1/2 trial of Bellicum’s cancer cell therapy BPX-601, Share XFDA puts Bellicum’s cancer cell therapy trial on holdhttps://pharmaphorum.com/news/fda-puts-bellicums-cancer-cell-therapy-trial-on-hold/
AZ’s COVID-19 vaccine trial ready to resume in US – reportsAstraZeneca’s COVID-19 vaccine trial could be ready to resume this week in the US after a seven-week hiatus Share XAZ’s COVID-19 vaccine trial ready to resume in US – reportshttps://pharmaphorum.com/news/azs-covid-19-vaccine-trial-ready-to-resume-reports/
Lilly pauses COVID-19 antibody trial after factory hits trouble with FDAEli Lilly has put a clinical trial of its COVID-19 antibody therapy on hold after FDA inspectors found Share XLilly pauses COVID-19 antibody trial after factory hits trouble with FDAhttps://pharmaphorum.com/news/lilly-pauses-covid-19-antibody-trial-after-factory-hits-trouble-with-fda/
AZ resumes UK coronavirus vaccine trialAstraZeneca has resumed UK trials for its coronavirus vaccine, after the country’s medicines regulator gave the all-clear following Share XAZ resumes UK coronavirus vaccine trialhttps://pharmaphorum.com/news/az-resumes-uk-coronavirus-vaccine-trial/
WHO halts hydroxychloroquine trial in COVID-19 following safety concernsThe World Health Organisation has halted clinical tests of hydroxychloroquine against COVID-19, after safety concerns emerged in a Share XWHO halts hydroxychloroquine trial in COVID-19 following safety concernshttps://pharmaphorum.com/news/who-halts-hydroxychloroquine-trial-in-covid-19-following-safety-concerns/
EU regulators warn over safety of Trump’s favourite COVID drugsAs the search for therapies for COVID-19 continues, European regulators have urged caution over the cardiac side-effects of Share XEU regulators warn over safety of Trump’s favourite COVID drugshttps://pharmaphorum.com/news/eu-regulators-warn-over-safety-of-trumps-favourite-covid-drug/
Servier to acquire Danish cancer biotech SymphogenFrance’s Servier has signed a deal to buy the Danish biotech Symphogen, which specialises in antibody-based therapies for Share XServier to acquire Danish cancer biotech Symphogenhttps://pharmaphorum.com/news/servier-to-acquire-danish-biotech-symphogen/
FDA says all ranitidine drugs should be recalled on safety concernsThe FDA has asked drugmakers to pull all prescription and over-the-counter products based on ranitidine off the market Share XFDA says all ranitidine drugs should be recalled on safety concernshttps://pharmaphorum.com/news/fda-says-all-ranitidine-drugs-should-be-recalled-on-safety-concerns/
CHMP backs safety of anticoagulants after real-world studyThe EMA’s human drugs advisory committee has said that no change is needed to the use of direct Share XCHMP backs safety of anticoagulants after real-world studyhttps://pharmaphorum.com/news/chmp-backs-safety-of-anticoagulants-after-real-world-study/
